In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • A study led by Dr. Richard Gelber found that treating HER-2 positive breast cancer for one year with trastuzumab remains the standard of care. Researchers compared outcomes of the standard one-year course to a two-year treatment and a six-month treatment, and determined the one-year course was most beneficial.

Tags: BreastCancer

  • Dana-Farber patient Tara Shuman of Canton, who was diagnosed with breast cancer in August 2012, chronicles her journey and shares how she gained perspective and awareness during her battle with the disease.

Tags: BreastCancer

  • Dr. Hal Burstein and Dr. Ines Vaz-Luis comment on a study that shows diagnosis of breast cancer at an early stage remains vital.

Tags: BreastCancer

  • Children diagnosed with cancer remain at risk from a variety of serious, long-term complications. Dr. Lisa Diller from Dana-Farber/Children's Hospital Cancer Center says that new treatments can mitigate these risks for the next generation of pediatric cancer survivors.

Tags: BreastCancer, ChildhoodCancer, Survivorship

  • Dr. Eric Winer and Dr. Sara Tolaney led a study showing women with small stage 1, HER2-positive breast tumors, who received a combination of lower-intensity chemotherapy and a targeted drug following surgery, were unlikely to have the cancer recur within three years of treatment.

Tags: BreastCancer

  • Dr. Ann Partridge comments on breast cancer patients who are pregnant and how they should be vigilant about reporting any symptoms to their doctor.

Tags: BreastCancer

  • A Dana-Farber patient talks about the Executive Council luncheon aimed at supporting the Susan F. Smith Center for Women’s Cancers at the Institute.

Tags: BreastCancer

  • The Dana-Farber Mammography Van and the Blum Family Van travel around the Greater Boston area providing cancer screenings.


Tags: BreastCancer, PatientSupport, YawkeyCenter, Prevention, Imaging

  • Dana-Farber researchers, including Dr. Kornelia Polyak, have developed a mathematical model to predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.

Tags: BreastCancer, Genomics

  • Research by Shoshana Rosenberg, ScD, shows that most breast cancer patients under 40 choose to have a mastectomy, even though a less radical lumpectomy procedure, combined with radiation, has the same overall survival.

Tags: BreastCancer

Showing 21-30 of 99 items